We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$734B
AUM Growth
-$36.7B
Cap. Flow
+$3.56B
Cap. Flow %
0.48%
Top 10 Hldgs %
15.88%
Holding
8,241
New
197
Increased
3,111
Reduced
3,746
Closed
238

Sector Composition

Rank Sector Weight
1 Technology 17.71%
2 Healthcare 11.34%
3 Financials 9.38%
4 Consumer Discretionary 8.31%
5 Communication Services 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNE
7226
DELISTED
Blue Horizon BNE ETF
BNE
$2K ﹤0.01%
+102
New +$2.44K
BGXX
7227
DELISTED
Bright Green Corporation Common Stock
BGXX
$2K ﹤0.01%
2,020
+20
+1% +$31
NEXI
7228
DELISTED
NexImmune, Inc. Common Stock
NEXI
$2K ﹤0.01%
137
-533
-80% -$15.6K
THMO
7229
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$2K ﹤0.01%
168
GRTX
7230
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$2K ﹤0.01%
1,082
-3,025
-74% -$4.28K
BPTH
7231
DELISTED
Bio-Path Holdings Inc
BPTH
$2K ﹤0.01%
35
-443
-93% -$33.6K
CHIC
7232
DELISTED
Global X MSCI China Communication Services ETF
CHIC
$2K ﹤0.01%
209
FRTX
7233
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$2K ﹤0.01%
+870
New +$2.52K
ITCL
7234
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$2K ﹤0.01%
1,117
-279
-20% -$867
AAC.WS
7235
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$2K ﹤0.01%
13,080
ALLG.WS
7236
DELISTED
Allego N.V. Warrants
ALLG.WS
$2K ﹤0.01%
4,155
BTWNU
7237
DELISTED
Bridgetown Holdings Limited Units
BTWNU
$2K ﹤0.01%
241
-800
-77% -$8.02K
MPRAU
7238
DELISTED
Mercato Partners Acquisition Corporation Unit
MPRAU
$2K ﹤0.01%
200
QFTA.U
7239
DELISTED
Quantum FinTech Acquisition Corporation Units, each consisting of one share of Common Stock and one Warrant
QFTA.U
$2K ﹤0.01%
+250
New +$2.47K
WEJO
7240
DELISTED
Wejo Group Limited Common Shares
WEJO
$2K ﹤0.01%
2,485
-56
-2% -$73
KSICU
7241
DELISTED
Kadem Sustainable Impact Corporation Unit
KSICU
$2K ﹤0.01%
200
HYRE
7242
DELISTED
HyreCar Inc. Common Stock
HYRE
$2K ﹤0.01%
2,186
-160,914
-99% -$150K
NH
7243
DELISTED
NantHealth, Inc
NH
$2K ﹤0.01%
577
-2,318
-80% -$16.5K
HLAHU
7244
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Unit
HLAHU
$2K ﹤0.01%
220
PV.WS
7245
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$2K ﹤0.01%
12,928
FSSIW
7246
DELISTED
Fortistar Sustainable Solutions Corp. Warrant
FSSIW
$2K ﹤0.01%
29,671
SECO
7247
DELISTED
Secoo Holding Limited ADR
SECO
$2K ﹤0.01%
629
+4
+0.6% +$11
NOAC
7248
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
$2K ﹤0.01%
241
CALA
7249
DELISTED
Calithera Biosciences, Inc
CALA
$2K ﹤0.01%
680
BLPH
7250
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$2K ﹤0.01%
1,470
-3
-0.2% -$4

Similar funds

Morgan Stanley's Q3 2022 Portfolio in Review

As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
  • Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
  • Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
  • Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
  • Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
  • Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.